Section V
41 – 50 of 11000
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Shiga toxin in extracellular vesicles is more potent than toxin alone in a mouse model of kidney disease
(2025) International Society for Extracellular Vesicles 2025
- Contribution to conference › Abstract
-
Mark
Angiotensinogen and C3 compete for renin-induced complement activation
- Contribution to journal › Article
-
Mark
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
- Contribution to journal › Article
-
Mark
Temporal Shift When Comparing Contrast-Agent Concentration Curves Estimated Using Quantitative Susceptibility Mapping (QSM) and ΔR2* : The Association Between Vortex Parameters and Oxygen Extraction Fraction
- Contribution to journal › Article
-
Mark
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
- Contribution to journal › Scientific review
-
Mark
Antibody-guided identification of Achromobacter xylosoxidans protein antigens in cystic fibrosis.
- Contribution to journal › Article
-
Mark
The effect of elexacaftor-tezacaftor-ivacaftor on liver stiffness in children with cystic fibrosis
- Contribution to journal › Article
-
Mark
Collagen VII is associated with airway remodeling, honeycombing and fibroblast foci in UIP/IPF
- Contribution to journal › Article
-
Mark
3D Quantitative MRI : A Fast and Reliable Method for Ventricular Volumetry
- Contribution to journal › Article
-
Mark
Extra-uterine placental transfusion and intact-cord stabilisation of moderately preterm to term infants in caesarean deliveries - A feasibility study with historical control (INTACT-2)
- Contribution to journal › Article
